A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease
Clinical trial NCT00253201 · COMPLETED
Trial details
- NCT number
- NCT00253201
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 636
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.